CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HBM Healthcare Investments AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HBM Healthcare Investments AG
Bundesplatz 1
Phone: +41 417107577p:+41 417107577 ZUG, 6300  Switzerland Ticker: HBMNHBMN

Business Summary
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
6799 Investors, not elsewhere classified

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Hans P.Hasler 67 6/25/2010 9/4/2009
Chief Executive Officer AndreasWicki 64 1/1/2001 1/1/2001
Chief Financial Officer ErwinTroxler 53 11/1/2011 11/1/2011
5 additional Officers and Directors records available in full report.

Business Names
Business Name
0QOC
5H5A
HBM BioVentures AG
HBMN
HBMNE

General Information
Number of Employees: 330 (As of 3/31/2015)
Outstanding Shares: 6,911,380 (As of 12/31/2023)
Shareholders: 3,916
Stock Exchange: SWF
Fax Number: +41 417107578


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024